Evidence of brain target engagement in Parkinson’s disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials

Publication Year: 2023

Journal: Journal of Nanobiotechnology

Author(s): Jimin Ren; Richard Dewey III; Austin Rynders; Jacob Evans; Jermey Evans; Benjamin Greenberg

Source: https://doi.org/10.1186/s12951-023-02236-z

Indication: Parkinson’s Disease

Therapeutic Area: Neuroscience

Keywords: Multiple Sclerosis; Catalytic gold nanotherapeutic; Target engagement; Drug development; Neuroimaging; Brain energy metabolites; Magnetic resonance spectroscopy

Request for Information

Fill out this form for access to the database.